In-vitro Skin Models: Development of Topical and Transdermal Formulations

May 15, 2020
MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany

Sponsored Content

In this seminar, we will talk about two different models that can be used for various in-vitro tests. On demand presentation Register free

Register Free: http://www.pharmtech.com/pt_w/skinmodels

Event Overview:

Transdermal/topical formulations are used in both the pharmaceutical and personal care industries, as they offer some clear benefits to targeted delivery. Human/animal skin models are commonly used for in-vitro testing of these formulations, but these models have multiple challenges, especially in the ever-changing regulatory landscape. As a result, researchers are seeking other options. In this seminar, we will talk about two different models that can be used for various in-vitro tests:

  • A synthetic membrane model (Strat-M® membrane) for in-vitro diffusion testing

  • An organotypic skin model for toxicity and irritation potential studies

Key Learning Objectives

  • Need for in-vitro models in transdermal/topical formulation research

  • Use of a synthetic membrane model (Strat-M® membrane) for in-vitro permeation testing

  • Use of organotypic skin model for toxicity and irritation potential studies

Speaker: Vivek Joshi, PhD, Applications and Market Adoption Manager, Merck KGaA, Darmstadt, Germany

Time and Date: On demand presentation

Sponsor: MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany

Register Free: http://www.pharmtech.com/pt_w/skinmodels